261 related articles for article (PubMed ID: 28821465)
1. Polymer-lipid hybrid systems used as carriers for insulin delivery.
Grigoras AG
Nanomedicine; 2017 Nov; 13(8):2425-2437. PubMed ID: 28821465
[TBL] [Abstract][Full Text] [Related]
2. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
3. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
4. Lipid-Drug Conjugate for Enhancing Drug Delivery.
Irby D; Du C; Li F
Mol Pharm; 2017 May; 14(5):1325-1338. PubMed ID: 28080053
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Characterization of Hypoglycemic Nanoparticles for Oral Insulin Delivery.
Zhang L; Zhang YX; Qiu JN; Li J; Chen W; Guan YQ
Biomacromolecules; 2017 Dec; 18(12):4281-4291. PubMed ID: 29059517
[TBL] [Abstract][Full Text] [Related]
6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
7. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
8. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.
Chaudhury A; Das S
AAPS PharmSciTech; 2011 Mar; 12(1):10-20. PubMed ID: 21153572
[TBL] [Abstract][Full Text] [Related]
9. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
10. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
11. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
Wong CY; Al-Salami H; Dass CR
J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
[TBL] [Abstract][Full Text] [Related]
12. Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability.
Anwer MK; Ali EA; Iqbal M; Ahmed MM; Aldawsari MF; Saqr AA; Ansari MN; Aboudzadeh MA
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011397
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
14. A review of biodegradable polymeric systems for oral insulin delivery.
Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
[TBL] [Abstract][Full Text] [Related]
15. Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids.
García-Díaz M; Foged C; Nielsen HM
Int J Pharm; 2015 Mar; 482(1-2):84-91. PubMed ID: 25445991
[TBL] [Abstract][Full Text] [Related]
16. Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.
Socha M; Sapin A; Damgé C; Maincent P
Drug Deliv; 2009 Nov; 16(8):430-6. PubMed ID: 19839787
[TBL] [Abstract][Full Text] [Related]
17. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
18. Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system.
Al-Remawi M; Elsayed A; Maghrabi I; Hamaidi M; Jaber N
Pharm Dev Technol; 2017 May; 22(3):390-398. PubMed ID: 27470482
[TBL] [Abstract][Full Text] [Related]
19. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
